Related Experiment Videos
Determining a range of false-positive rates for which ROC curves differ
1Department of Biostatistics, Medical College of Virginia, Richmond, VA 23298.
Summary
Comparing diagnostic tools requires analyzing their true-positive rates across specific false-positive ranges. This method directly compares ROC curves, revealing where screening or prognostic tools differ significantly.
Area of Science:
- Biostatistics
- Medical Informatics
- Diagnostic Accuracy
Background:
- Receiver Operating Characteristic (ROC) curves are vital for evaluating diagnostic/prognostic tool performance.
- Existing global summary measures for ROC curves may not be optimal for direct comparisons.
- Comparing two ROC curves often requires nuanced analysis beyond single summary indices.
Purpose of the Study:
- To introduce a method for directly comparing true-positive rates of two diagnostic, screening, or prognostic tools.
- To determine the specific range of false-positive values over which two ROC curves differ.
- To provide a flexible method applicable to both independent and dependent samples.
Main Methods:
- Direct comparison of true-positive rates between two ROC curves.
- Identification of the range of false-positive values where significant differences exist.
- Application of the method to independent and dependent sample data.
Main Results:
- The proposed method effectively identifies ranges where diagnostic tools exhibit differing performance.
- Demonstrated applicability using examples from medical imaging (gallium citrate) and critical care prognostics (ICU severity index).
- Quantified the specific false-positive rate intervals for which the compared ROC curves diverge.
Conclusions:
- The presented method offers a direct and effective approach for comparing ROC curves, especially when global measures are insufficient.
- It precisely pinpoints performance differences between diagnostic tools within specific operating ranges.
- This technique enhances the comparative analysis of medical diagnostic, screening, and prognostic tools.